In a report published Thursday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on HCA Holdings HCA, and raised the price target from $65.00 to $67.00.
In the report, Morgan Stanley noted, “HCA raised its EBITDA guidance to $7B to $7.15B reflecting TX Medicaid payments and an improved reform outlook. We updated our ‘14 EBITDA estimate to $7.15B, the high end of guidance, reflecting our expectations for a 2.8% reform benefit. We remain OW and raise our PT to $67.”
HCA Holdings closed on Wednesday at $60.99.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in